Table 3. Pooled estimates of the percentage of manifestations among symptomatic NCC patients using random-effect binomial models.
Manifestation | Age group | ||
All | Children | Adults | |
Seizures/epilepsy | 78.8% (65.1%; 89.7%) | 78.9% (70.5%; 86.2%) | 63.2% (51.9%; 73.8%) |
Headaches | 37.9% (23.3%; 53.7%) | 27.7% (20.7%; 35.2%) | 25.9% (10.7%; 45.0%) |
Signs of Intracranial Pressure/Hydrocephalus/Papilledema | 11.7% (6.0%; 18.9%) | 22.7% (10.2%; 38.5%) | 16.3% (5.3%; 31.8%) |
Meningitis symptoms | 7.9% (2.7%; 15.5%) | 11.2% (5.2%; 19.0%) | 5.6% (1.9%; 12.8%)* |
Cranial nerve palsy | 2.8% (0.1%; 14.5%)* | 6.0% (0.6%; 16.2%) | NA |
Gait abnormality/ataxia | 6.0% (1.9%; 12.1%) | 2.4% (0.2%; 7.2%) | 5.6% (1.9%; 12.8%)* |
Focal deficits | 16.0% (9.7%; 23.6%) | 12.5% (7.6%; 18.4%) | 11.8% (4.1%; 22.9%) |
Visual changes | 5.6% (1.1%; 13.5%) | 3.5% (1.3%; 6.7%) | NA |
Altered mental state/psychiatric symptoms | 4.5% (1.5%; 9.0%) | 4.0% (0.5%; 13.4%)* | 28.1% (0.5%; 74.9%) |
Pyramidal signs | NA | 11.6% (0.0%; 42.9%) | NA |
*: One study with binomial 95%CI.
NA: No data Available.